A Study of LY3015014 in Participants With High Cholesterol
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 527 participants.
Also called NCT01890967
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 527 participants
- Sponsor
- Registry
-
NCT01890967
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Canada, Czechia, Denmark, Japan, Netherlands, Poland, Puerto Rico
- Registry status
- Completed
Technical summary
Registry record NCT01890967. Randomized; double masking; primary purpose treatment. Start 2013-06 (registry gives no type); primary completion 2014-04 (actual). Results posted on 2017-06-21.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of LY3015014 in Participants With High Cholesterol
- Condition
- Hypercholesterolemia
- Intervention (Drug)
- LY3015014
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- Statin
- Intervention (Drug)
- Ezetimibe
- Lead sponsor
- Eli Lilly and Company
Record details
- Record id
cardio:ct-nct01890967- Content hash
833d123adfc30b63140275f204d3f1bfa56b5c14fe4cf4161e29e0b6baf555ee